Methods: Serum s-Flt-1 and PlGF and their ratio pre-eclamptic index (PEI) were measured in a case-control study of patients that developed PE before or after 34 weeks and unaffected controls. Pre-eclampsia was defined by blood pressure > 140/90mmHg and proteinuria > 300mg/24h. We analysed s-Flt-1 and PlGF (Brahms Kryptor). PEI was calculated for patients before and after 34 weeks of pregnancy. We observed gestational age at delivery (GA), incidence of PE, HELLP syndrome, FGR, SGA, IUFD and perinatal outcomes. Statistical analysis was performed using IBM SPSS Statistics 24. Results: Our study included 339 patients. Average maternal age was 32.9 years, average BMI 24.9, 43% was primigravids and 56% was nulliparous. Patients with subsequent adverse outcomes (n=87) had significantly higher sFlt-1, lower PlGF and higher PEI than women without adverse outcomes (n=252), p<0.001. PEI ratio correlated with prematurity. GA was significantly lower in the PE group: 34.7 vs 39.5 weeks, p<0.001.
Objectives:
The purpose of the study was to evaluate the role of sFlt-1 / PLGF ratio (below or above the 95th percentile) in pregnancy complicated by early severe pre-eclampsia. Methods: The study included 34 patients with early severe pre-eclampsia in the second and third trimester of pregnancy (24-32 weeks). The concentrations of (sFlt-1 / PLGF) ratio were measured at the time of diagnosis of early severe pre-eclampsia with the use of The Elecsys immunoassays for sFlt-1 and PlGF (Roche Diagnostics). Results: In this group of patients with early severe pre-eclampsia we observed that the higher levels of (sFlt-1 / PLGF) ratio (> p 95) (n=14) were associated with the shorter time of pregnancy lasting (3.04 weeks) and the lower neonatal weight (1421 gr).When compared to the group of patients with severe pre-eclampsia with a lower (sFlt-1 / PLGF) ratio < p95 (n=18) , time of pregnancy lasting (8.2 weeks) (p<0.001) and neonatal weight (2802 gr)(p<0.001) respectively. Conclusions: Pregnancy complicated by early severe pre-eclampsia and higher levels of (sFlt-1 / PLGF) ratio (above p > 95) were associated with worse perinatal outcomes -shorter time of pregnancy lasting and lower neonatal weight. These observations suggest the potential role of these markers in monitoring of pre-eclampsia.
The determination of these angiogenic factors in clinical practice may be a good monitoring tool for detection of complications and help with decision making. A rise in sFlt-1 ratio / PLGF > p95 Is associated with a high risk of adverse perinatal outcome. Objectives: Intrauterine growth restriction (IUGR) and pre-eclampsia (PE) are two major pathologies related to placental vascular insufficiency. Uteroplacental vascularisation was quantified with 3D power Doppler (3DPD) in the third trimester in two populations: normal and impaired pregnancies (PE and/or IUGR). Methods: 84 women with normal pregnancy and 28 women with PE and/or IUGR pregnancies were prospectively included in this study. Utero-placental 3DPD acquisitions were performed within 72 hours before delivery using standardised machine settings. Placenta and beneath myometrium volumes were manually traced separately with the VOCAL imaging analysis software. 3DPD indices -vascularisation index (VI), flow index (FI) and vascularisation-flow index (VFI) -were calculated in each volume and compared between the 2 groups. The impact of placental position and body mass index (BMI) on 3DPD indices was also evaluated. Results: The placental and myometrial volumes were not significantly different between normal and pathological pregnancies. The traced placental volumes were significantly reduced in case of posterior placenta (n=63) (p<0.001). Placental VI, FI and VFI were significantly reduced in PE and/or IUGR pregnancies (n= 28) compared with normal pregnancies (n= 84) ((p<0.01), for myometrium, only FI was significantly reduced in PE and/or IUGR pregnancies (p=0.02). Placental 3DPD indices (VI, FI and VFI) were significantly reduced in posterior placental cases or in the patients with BMI>25 Kg/m 2 (n=48) (p<0.001). There was no impact of placental position or BMI on myometrial volume. Only myometrial FI was significantly reduced in posterior placental cases (p<0.05). Conclusions: 3DPD assessment of placental vascular indices has the potential for PE and or IUGR pregnancy diagnosis in the third trimester, the myometrial FI might be an interesting index for PE and or IUGR identification that isn't influenced by patient's BMI.
